Software - ANVISA Registration 81504790393
Access comprehensive regulatory information for Software in Brazil's medical device market through Pure Global AI's free database. This Risk Class I medical device is registered under ANVISA number 81504790393 and manufactured by FUTURE FERTILITY INC.. The registration is held by PASSROD IMPORTAÇÃO E EXPORTAÇÃO DE PRODUTOS PARA SAÚDE LTDA - ME with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including PHILIPS MEDICAL SYSTEMS NEDERLAND B.V., CARDIO SISTEMAS COMERCIAL E INDUSTRIAL LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
81504790393
25351080567202488
26185222000110
Company Information
Dates and Status
Apr 01, 2024
VIGENTE
09/18/2025 19:00:01
Software
Future Fertility Oocyte Software
FUTURE FERTILITY INC.
83084440002
Aug 18, 2025
Software
EMBRYOAID
MIM FERTILITY SP. Z O.O.
82167460004
Apr 28, 2025
Software
FetView
PHILIPS ULTRASOUND LLC.
10216710407
Nov 13, 2023
Software
ADA HEALTH
ADA HEALTH GMBH
81504790259
May 20, 2021
Software
Natural Cycles
NATURALCYCLES NORDIC AB
81987060011
Mar 05, 2025
Software
Calculadora VDZ-CDST
TAKEDA PHARMACEUTICALS U.S.A., INC.
80147410026
Sep 15, 2025
Software
P4C
DEDALUS ITALIA SPA
81806320006
Sep 15, 2025
Software
AFOOT AI
LOOKINSIDE SERVICOS E TECNOLOGIAS LTDA
83126510001
Sep 08, 2025
Software
MV PEP
MV SISTEMAS DE MEDICINA DIAGNOSTICA LTDA
80436840006
Sep 08, 2025
Software
Future Fertility Oocyte Software
FUTURE FERTILITY INC.
83084440002
Aug 18, 2025